A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications. (2012)

First Author: Corrie PG
Attributed to:  Hub in Trials Methodology Research (MRC Biostatistics Unit, Cambridge) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/bjc.2012.318

PubMed Identifier: 22814578

Publication URI: http://europepmc.org/abstract/MED/22814578

Type: Journal Article/Review

Volume: 107

Parent Publication: British journal of cancer

Issue: 4

ISSN: 0007-0920